Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-070583
Filing Date
2021-05-21
Accepted
2021-05-21 17:52:32
Documents
1
Period of Report
2021-05-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2116949-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2116949-1_4seq1.xml 4 7052
  Complete submission text file 0001104659-21-070583.txt   8533
Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address
Shah Rajeev M. (Reporting) CIK: 0001619841 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 21950434

Mailing Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)